Rare diseases
Investigational molecules
Locations
Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
FranceStudy of Elafibranor for Adults with Primary Biliary Cholangitis
FranceStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
FranceStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
FranceStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
FranceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
FranceStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
FranceStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
FranceStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
